ABIONYX Pharma SA (EPA:ABNX)
France
· Delayed Price · Currency is EUR 3.270
-0.025 (-0.76%)
Mar 9, 2026, 5:35 PM CET
ABIONYX Pharma Revenue
ABIONYX Pharma had revenue of 2.12M EUR in the half year ending June 30, 2025, a decrease of -0.42%. This brings the company's revenue in the last twelve months to 4.33M, down -10.91% year-over-year. In the year 2024, ABIONYX Pharma had annual revenue of 4.55M, down -1.92%.
Revenue (ttm)
4.33M
Revenue Growth
-10.91%
P/S Ratio
26.67
Revenue / Employee
84.82K
Employees
51
Market Cap
115.36M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sensorion | 5.65M |
| Adocia | 12.88M |
| MaaT Pharma | 3.92M |
| Innate Pharma | 12.64M |
| OSE Immunotherapeutics | 1.78M |
| Valerio Therapeutics Société anonyme | 1.83M |
| Transgene | 7.58M |
| Cellectis | 70.36M |